Literature DB >> 22336566

Factors related to orthostatic hypotension in Parkinson's disease.

Santiago Perez-Lloret1, María Verónica Rey, Nelly Fabre, Fabienne Ory, Umberto Spampinato, Jean-Michel Senard, Anne Pavy-Le Traon, Jean-Louis Montastruc, Olivier Rascol.   

Abstract

INTRODUCTION: Orthostatic hypotension (OH), a frequent feature of Parkinson's disease (PD) can contribute to falls and is usually related to the disease itself and/or to drugs.
OBJECTIVES: To explore factors related to OH and to assess the concordance between abnormal blood pressure (BP) fall after standing and the presence of orthostatic symptoms.
METHODS: Non-demented, non-operated idiopathic PD out-patients were questioned about the presence of orthostatic symptoms. Afterward, BP was measured 5-min after lying down and for 3-min after standing up. OH was defined as systolic and/or diastolic BP fall ≥ 20 and/or 10 mmHg after standing. Patients were further evaluated by the Unified PD Rating Scale (UPDRS) and their medications were recorded.
RESULTS: 103 patients were included in this study (mean age = 66 ± 1 years, mean disease duration = 9 ± 1 years; mean UPDRS II+III in ON-state = 37 ± 2 points). Forty-one subjects (40%) reported the presence of orthostatic symptoms during the previous week and 38 (37%) had OH according to manometric definition. Independent factors related to OH, as assessed by logistic regression were age >68 years (OR, 95% CI=3.61, 1.31-9.95), polypharmacy (defined as intake of >5 medications, OR = 3.59, 1.33-9.69), amantadine (7.45, 1.91-29.07) or diuretics (5.48, 1.10-54.76), whereas the consumption of entacapone was protective (0.20, 0.05-0.76). The agreement between abnormal BP fall and presence of orthostatic symptoms was poor (kappa = 0.12 ± 0.1, p = 0.23).
CONCLUSION: OH was significantly related to older age, polypharmacy and amantadine or diuretics intake, while entacapone exposure appeared to reduce the risk of OH. Low concordance between OH and orthostatic symptoms was observed.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22336566     DOI: 10.1016/j.parkreldis.2012.01.012

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  12 in total

1.  Falls in ambulatory non-demented patients with Parkinson's disease.

Authors:  Olivier Rascol; Santiago Perez-Lloret; Philippe Damier; Arnaud Delval; Pascal Derkinderen; Alain Destée; Wassilios G Meissner; Francois Tison; Laurence Negre-Pages
Journal:  J Neural Transm (Vienna)       Date:  2015-04-07       Impact factor: 3.575

Review 2.  Efficacy and safety of amantadine for the treatment of L-DOPA-induced dyskinesia.

Authors:  Santiago Perez-Lloret; Olivier Rascol
Journal:  J Neural Transm (Vienna)       Date:  2018-03-07       Impact factor: 3.575

Review 3.  Current Concepts in the Treatment of Multiple System Atrophy.

Authors:  Santiago Perez-Lloret; Olivier Flabeau; Pierre-Olivier Fernagut; Anne Pavy-Le Traon; María Verónica Rey; Alexandra Foubert-Samier; Francois Tison; Olivier Rascol; Wassilios G Meissner
Journal:  Mov Disord Clin Pract       Date:  2015-02-02

Review 4.  Orthostatic hypotension in patients with Parkinson's disease and atypical parkinsonism.

Authors:  Seyed-Mohammad Fereshtehnejad; Johan Lökk
Journal:  Parkinsons Dis       Date:  2014-02-02

5.  Cognitive impairments in Parkinson's disease: Evidence from an Iranian population.

Authors:  Farzad Ashrafi; Alireza Zali; Hossein Pakdaman; Karim Johari
Journal:  Iran J Neurol       Date:  2012

6.  Use of Fall-Risk Inducing Drugs in Patients Using Anti-Parkinson Drugs (APD): A Swedish Register-Based Study.

Authors:  Ylva Haasum; Johan Fastbom; Kristina Johnell
Journal:  PLoS One       Date:  2016-08-18       Impact factor: 3.240

7.  Borg scale is valid for ratings of perceived exertion for individuals with Parkinson's disease.

Authors:  Amanda L Penko; Jacob E Barkley; Mandy Miller Koop; Jay L Alberts
Journal:  Int J Exerc Sci       Date:  2017-01-01

Review 8.  Neurogenic Orthostatic Hypotension in Parkinson Disease: A Primer.

Authors:  Jeremy K Cutsforth-Gregory; Phillip A Low
Journal:  Neurol Ther       Date:  2019-08-27

9.  The management of orthostatic hypotension in Parkinson's disease.

Authors:  Alvaro Sánchez-Ferro; Julián Benito-León; Juan Carlos Gómez-Esteban
Journal:  Front Neurol       Date:  2013-06-10       Impact factor: 4.003

10.  Drug-Related Orthostatic Hypotension: Beyond Anti-Hypertensive Medications.

Authors:  Giulia Rivasi; Martina Rafanelli; Enrico Mossello; Michele Brignole; Andrea Ungar
Journal:  Drugs Aging       Date:  2020-10       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.